European Archives - Page 366 of 1054 - European Medical Journal

Nothing About Me Without Me: Shared Decision-Making in Chronic Hepatitis B

Hepatitis B affects more than 296 million people worldwide, according to the World Health Organization (WHO). More than 1.5 million new infections occur each year, despite the availability of safe and effective vaccines.

Challenging the postcode health lottery

A postcode can determine health outcomes more than genetics. How can pharma help to solve the postcode lottery?

Prevalence of SARS-CoV-2 Cellular and Humoral Immunity Amongst Patients on Dialysis After the First Vaccination Campaign

Global immunisation against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the standard-of-care in preventing COVID-19…

Anti-TNF Treatment in Crohn’s Disease Complicated by Intra-abdominal Abscess

Excess production of TNF-α leads to chronic inflammation and tissue damage in immune-mediated inflammatory diseases (IMID) such as Crohn’s Disease (CD), rheumatoid arthritis, and psoriasis. The introduction of anti-TNF agents revolutionised therapy for patients with IMIDs, and two anti-TNFs are currently approved for use in CD in Europe: infliximab and adalimumab.

EMJ Gastroenterology 11 [Supplement 8] 2022

This mini-review is the fourth in a series exploring TNF inhibitors in treating immune-mediated inflammatory disease. Specifically, this mini-review summarises the evidence of anti-TNFs in Crohn’s disease (CD) complicated by intra-abdominal abscess.

Virtual Reality to Reality - The Impact of Charities on Health

Jonathan is joined by film producer Peter Samuelson for an in-depth discussion on the work carried out by his award-winning charities. Listen now!

Turning patient insights into action

Pharma endeavours to drive positive action from patient insights. Read to find out how they could improve their methodologies and outcomes.

Using Behavioral Science to Help Understand Vaccine Hesitancy

This video details Graves’ research on vaccine hesitancy and the psychological and sociocultural factors behind it. Learn ways to identify and overcome vaccine hesitancy by using valuable, research-based insights and strategies.

Mitigating the rare disease RWD deficit

RWD for rare diseases is scarce, but pharma can work to leverage existing processes and build trust to enhance the scope of available data.

Sales reps, MSLs and the future of CX

In this episode, the team chat to James Harper, Founder and Managing Director, Twentyeightb, about pharma sales, MSLs and more.